Luna Innovations extends its development and supply agreement with Intuitive Surgical

NewsGuard 100/100 Score

Luna Innovations Incorporated (NASDAQ: LUNA) announced today that it will be extending its development and supply agreement with Intuitive Surgical, Inc. (NASDAQ: ISRG) to continue integrating Luna’s shape sensing technology into Intuitive’s products.

“This new agreement with Intuitive Surgical will continue Luna’s relationship with the leader in the medical robotics market and further demonstrates the potential of our technology and intellectual property”

In June 2007, Luna and Intuitive entered into a multi-year development and supply agreement in which Luna would supply its fiber optic based shape sensing system for integration into Intuitive’s medical robotics products and license its shape sensing technology to Intuitive for this purpose. Intuitive Surgical is the global technology leader in robotic-assisted minimally invasive surgery and its products include the da Vinci® Surgical System. Luna has successfully achieved the expectations of the development work in the original agreement, which concluded in December of 2009.

Luna and Intuitive will be extending their development and supply agreement to further develop Luna’s technology for its products.

"This new agreement with Intuitive Surgical will continue Luna’s relationship with the leader in the medical robotics market and further demonstrates the potential of our technology and intellectual property,” stated Kent Murphy, Luna's Chairman and Chief Executive Officer. "It has been a great relationship over the past thirty months, and it is extremely rewarding to know that Luna's technology will be assisting in complex minimally invasive surgery in the pursuit of delivering the best outcome for patients."

“We continue to view Luna as a strong technology partner in the area of advanced shape sensing and position tracking systems,” said Dave Rosa, Intuitive’s Vice President of New Product Development. “Our development with Luna is progressing well and Intuitive remains committed to our joint project.”

Luna’s exclusive shape sensing system tracks the position of an optical fiber along its entire length, providing real-time measurements that can assist surgeons in navigating through the body. This technology could be particularly helpful in certain minimally invasive surgical techniques because of the need to track the position of medical instruments in the patient, using optical fibers as thin as a human hair to provide sensing and feedback as the nervous system does for the human body.

Luna will host a conference call with investors on Jan. 11, 2010, at 1:30 p.m. (EST) to discuss this and other announcements upon the company’s emergence from bankruptcy. The investor conference call will be available via live webcast on the Luna Innovations' website at http://www.lunainnovations.com/ under the tab "Investor Relations." To participate by telephone, the domestic dial-in number is 1.800.299.7928 and the international dial-in number is 1.617.614.3926. The participant access code is 97312544. Investors are advised to dial in at least five minutes prior to the call to register. The webcast will be archived on the company's website under "Webcasts and Presentations" for 30 days following the conference call.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study suggests high levels of vitamin B3 breakdown products are linked to higher risk of mortality, heart attacks, and stroke